Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cannabinoids decrease the th17 inflammatory autoimmune phenotype.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology - 1 Dec 2013

Kozela Ewa, Juknat Ana, Kaushansky Nathali, Rimmerman Neta, Ben-Nun Avraham, Vogel Zvi

Abstract excerpt

Cannabinoids, the Cannabis constituents, are known to possess anti-inflammatory properties but the mechanisms involved are not understood. Here we show that the main psychoactive cannabinoid, Δ-9-tetrahydrocannabinol (THC), and the main nonpsychoactive cannabinoid, cannabidiol (CBD), markedly red...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen-Presenting Cells
Share to Coculture Techniques
Share to Encephalomyelitis, Autoimmune, Experimental

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-gamma

Share to Interleukin-17

Share to Myelin-Oligodendrocyte Glycoprotein

Share to Peptide Fragments

Share to Th17 Cells

Source

Identifiers

PMID: 23892791
DOI: 10.1007/s11481-013-9493-1

Genes

TRPV1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23892791-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cannabinoids decrease the th17 inflammatory autoimmune phenotype.PMID 23892791Read ↗

Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cellsSemantic proximity Read ↗

Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune DiseaseSemantic proximity Read ↗

Phytocannabinoids Reduce Inﬂammation of Primed Macrophages and Enteric Glial CellsSemantic proximity Read ↗

Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 InfectionSemantic proximity Read ↗

Th17 Cell, the New Player of Neuroinflammatory Process in Multiple SclerosisSemantic proximity Read ↗

TH17 cytokines in autoimmune neuro-inflammationSemantic proximity Read ↗

Endocannabinoid signaling in brain diseases: Emerging relevance of glial cellsSemantic proximity Read ↗

Rethinking Alzheimer’s: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation ControlSemantic proximity Read ↗

Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation.Semantic proximity Read ↗

Toll-like receptor signalling as a cannabinoid targetSemantic proximity Read ↗

Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.Semantic proximity Read ↗

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson´s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.